Explore the Agenda

8:00 am Registration Opens & Morning Coffee

8:50 am Chair’s Opening Remarks

Associate Director, Drug Product Development, Aviceda Therapeutics

Introducing the Discovery of LNPs & Novel Targeting Strategies for Achieving Potent Extrahepatic Delivery

9:00 am Panel Discussion: Delving into the Discovery & Evolution of LNPs to Gain an Understanding of the Foundation & Future Potential for LNP Delivery

Senior Principal Scientist, Arbor Biotech
Director - Chemistry, Sanofi
Senior Director, Advanced Drug Delivery, AstraZeneca
  • Uncovering the origins of LNP technology and how they were initially discovered
  • Exploring the evolving role of LNPs from early gene delivery systems to their pivotal role in mRNA vaccine development
  • Showcasing the key scientific breakthroughs that have shaped modern LNP design

9:30 am Providing an Introduction into Targeted LNPs for Organ & Cell-Specific Delivery Beyond the Liver

Chief Technology Officer, Land Therapeutics
  • Diving into the fundamentals of targeted LNP design, including ligand selection and surface modifications
  • Reviewing the biological and formulation factors that influence tissue and cell specificity
  • Analyzing current applications and early strategies used to enhance precision and reduce off-target effects

NEW COMPANY

10:00 am Morning Networking Break

Spotlighting the Foundations of Formulation, Process Development & Manufacturing for High Quality LNP Development

11:00 am Deep Diving into LNP Formulations to Uncover How Lipid Chemistry Shapes Effective Delivery & Therapeutic Success

Associate Director, Drug Product Development, Aviceda Therapeutics
  • Breaking down the key components of LNPs, focusing on the functional roles of ionizable lipids, helper lipids, cholesterol, and PEG-lipids
  • Examining the principles of designing ionizable lipids to learn what makes them effective
  • Understanding how formulations are tailored to optimize stability, delivery efficiency, and payload compatibility

11:30 am Optimizing Pharmaceutical Properties of LNPs by Improving Composition & Components for Greater Potency

Director, Nanoparticle Formulation, Beam Therapeutics
  • Fine-tuning the structure and ratio of lipids to boost LNP delivery efficiency
  • Tailoring the cargo to unlock higher efficacy
  • Demonstrating how process optimization strengthens LNP stability, and ensures consistent pharmaceutical properties

12:00 pm Building a Foundation on LNP Process Development & Manufacturing to Achieve Product Consistency & Scalability

Director, Formulation Development & External Manufacturing, Alltrna
  • Showcasing the core steps in LNP process development to successfully translate from formulation to final product manufacturing
  • Highlighting the key parameters to assess that influence product quality and the critical quality attributes
  • Exploring fundamental strategies to ensure scalability, batch consistency, stability, and regulatory readiness

NEW COMPANY

12:30 pm Lunch & Networking

Overcoming the Key Bottlenecks of IP, Toxicity & Batch-to-Batch Variability for Accelerating Safe LNP Drug Products

1:30 pm An Overview of the Intellectual Property Trends for LNPs Including New Targeting Technologies

Patent Attorney, Rothwell Figg
  • Managing the crowded patent landscapes to secure and navigate third party rights relating to lipids, formulations, and delivery innovations
  • Delving into the targeting moieties and other technologies which are driving and evolving the IP landscape
  • Discussing the analytical framework for protecting the IP generated by research teams

2:00 pm Roundtable Discussion: Navigating Common but Critical Challenges Associated with LNPs to Build a Robust Toolkit for Developing Safe, Stable & Consistent LNPs

Chief Technology Officer, Land Therapeutics
  • Tackling common safety challenges of LNPs to enable redosability for more effective therapies
  • Discussing the causes and impact of batch-to-batch variability and gaining insights into practical approaches for improving consistency
  • Evaluating best practices for improving LNP stability and formulation to ensure global availability

3:00 pm Evaluating LNP Biology to Understand the Fundamental Properties that Impact Delivery Efficiency for Maximized Efficacy

, Delivery Expert
  • Deep diving into how LNPs circulate, distribute, and interact with biological systems after administration
  • Exploring the key characteristics influencing biodistribution, cellular uptake, and endosomal escape
  • Delving into how to measure LNP efficacy to evaluate therapeutic performance

3:30 pm Chair’s Closing Remarks

Associate Director, Drug Product Development, Aviceda Therapeutics

3:45 pm End of LNP 101 Day